Feedback
Pregabalin, Serum or Plasma
2011609
Ordering Recommendation

Optimize drug therapy and monitor patient adherence.

Mnemonic
PREGABALIN
Methodology
Quantitative Liquid Chromatography/Tandem Mass Spectrometry
Performed
Tue, Sat
Reported
1-6 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Serum Pre-dose (Trough) Draw - At a Steady State Concentration or Plasma Pre-dose (Trough) Draw - At a Steady State Concentration in Plain Red, Lavender (K2EDTA), Lavender (K3EDTA), or Pink (K2EDTA). 
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.2 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
Citrated Plasma. 
Remarks
Please indicate in the supplied fields:
1.  Dose - List drug amount and include the units of measure
2.  Route - List the route of administration (IV, oral, etc.)
3.  Dose Frequency - Indicate how often the dose is administered (per day, per week, as needed, etc.)
4.  Type of Draw - Indicate the type of blood draw (Peak, Trough, Random, etc.) 
Stability
Ambient: 1 month; Refrigerated: 1 month; Frozen: 2 months 
Reference Interval
Therapeutic RangeNot well established
ToxicNot well established

Interpretive Data
The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration. Therapeutic and toxic ranges are not well established. Proposed Dose-Related Range: 2-10 ug/mL. Adverse effects may include peripheral edema, allergic reactions, dizziness and somnolence.

Compliance Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Note
CPT Code(s)
Components
Component Test Code*Component Chart NameLOINC
2011610Pregabalin, Serum or Plasma47414-8
2011894Pregabalin Dose65818-7
2011895Pregabalin Route45373-8
2011896Pregabalin Dose Frequency52810-9
2011897Pregabalin Type of Draw49049-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Lyrica